Selected research
Market Analysis & Forecast
Global Tafenoquine Market Analysis and Forecast 2026-2032
Market perspective
The global Tafenoquine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tafenoquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Tafenoquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Tafenoquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Tafenoquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tafenoquine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Tafenoquine, also provides the sales of main regions and countries. Of the upcoming market potential for Tafenoquine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tafenoquine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tafenoquine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tafenoquine sales, projected growth trends, production technology, application and end-user industry.
Tafenoquine Segment by Company
Pharmacodia (Beijing) Co.,Ltd
Merck
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
BOC Sciences
Amadis Chemical Company Limited
Tafenoquine Segment by Type
Powder
Pills
Tafenoquine Segment by Application
P. falciparum Treatment
Radical Cure of P.vivax
Prevention of Malaria Relapse
Tafenoquine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Tafenoquine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tafenoquine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Pills
Applications
- P. falciparum Treatment
- Radical Cure of P.vivax
- Prevention of Malaria Relapse
Companies covered
- Pharmacodia (Beijing) Co.,Ltd
- Merck
- GlaxoSmithKline Pharmaceuticals (GSK)
- WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- J & K Scientific LTD
- BOC Sciences
- Amadis Chemical Company Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Tafenoquine Market by Type
- 1.2.1 Global Tafenoquine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Powder
- 1.2.3 Pills
- 1.3 Tafenoquine Market by Application
- 1.3.1 Global Tafenoquine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 P. falciparum Treatment
- 1.3.3 Radical Cure of P.vivax
- 1.3.4 Prevention of Malaria Relapse
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Tafenoquine Market Dynamics
- 2.1 Tafenoquine Industry Trends
- 2.2 Tafenoquine Industry Drivers
- 2.3 Tafenoquine Industry Opportunities and Challenges
- 2.4 Tafenoquine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Tafenoquine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Tafenoquine Revenue by Region
- 3.2.1 Global Tafenoquine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Tafenoquine Revenue by Region (2021-2026)
- 3.2.3 Global Tafenoquine Revenue by Region (2027-2032)
- 3.2.4 Global Tafenoquine Revenue Market Share by Region (2021-2032)
- 3.3 Global Tafenoquine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Tafenoquine Sales by Region
- 3.4.1 Global Tafenoquine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Tafenoquine Sales by Region (2021-2026)
- 3.4.3 Global Tafenoquine Sales by Region (2027-2032)
- 3.4.4 Global Tafenoquine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Tafenoquine Revenue by Manufacturers
- 4.1.1 Global Tafenoquine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Tafenoquine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Tafenoquine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Tafenoquine Sales by Manufacturers
- 4.2.1 Global Tafenoquine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Tafenoquine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Tafenoquine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Tafenoquine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Tafenoquine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Tafenoquine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Tafenoquine Manufacturers, Product Type & Application
- 4.7 Global Tafenoquine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Tafenoquine Market CR5 and HHI
- 4.8.2 2025 Tafenoquine Tier 1, Tier 2, and Tier 3
5 Tafenoquine Market by Type
- 5.1 Global Tafenoquine Revenue by Type
- 5.1.1 Global Tafenoquine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Tafenoquine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Tafenoquine Revenue Market Share by Type (2021-2032)
- 5.2 Global Tafenoquine Sales by Type
- 5.2.1 Global Tafenoquine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Tafenoquine Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Tafenoquine Sales Market Share by Type (2021-2032)
- 5.3 Global Tafenoquine Price by Type
6 Tafenoquine Market by Application
- 6.1 Global Tafenoquine Revenue by Application
- 6.1.1 Global Tafenoquine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Tafenoquine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Tafenoquine Revenue Market Share by Application (2021-2032)
- 6.2 Global Tafenoquine Sales by Application
- 6.2.1 Global Tafenoquine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Tafenoquine Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Tafenoquine Sales Market Share by Application (2021-2032)
- 6.3 Global Tafenoquine Price by Application
7 Company Profiles
- 7.1 Pharmacodia (Beijing) Co.,Ltd
- 7.1.1 Pharmacodia (Beijing) Co.,Ltd Company Information
- 7.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
- 7.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
- 7.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
- 7.2 Merck
- 7.2.1 Merck Company Information
- 7.2.2 Merck Business Overview
- 7.2.3 Merck Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck Tafenoquine Product Portfolio
- 7.2.5 Merck Recent Developments
- 7.3 GlaxoSmithKline Pharmaceuticals (GSK)
- 7.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
- 7.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
- 7.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
- 7.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
- 7.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- 7.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
- 7.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
- 7.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
- 7.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
- 7.5 J & K Scientific LTD
- 7.5.1 J & K Scientific LTD Company Information
- 7.5.2 J & K Scientific LTD Business Overview
- 7.5.3 J & K Scientific LTD Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
- 7.5.5 J & K Scientific LTD Recent Developments
- 7.6 BOC Sciences
- 7.6.1 BOC Sciences Company Information
- 7.6.2 BOC Sciences Business Overview
- 7.6.3 BOC Sciences Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 BOC Sciences Tafenoquine Product Portfolio
- 7.6.5 BOC Sciences Recent Developments
- 7.7 Amadis Chemical Company Limited
- 7.7.1 Amadis Chemical Company Limited Company Information
- 7.7.2 Amadis Chemical Company Limited Business Overview
- 7.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
- 7.7.5 Amadis Chemical Company Limited Recent Developments
8 North America
- 8.1 North America Tafenoquine Market Size by Type
- 8.1.1 North America Tafenoquine Revenue by Type (2021-2032)
- 8.1.2 North America Tafenoquine Sales by Type (2021-2032)
- 8.1.3 North America Tafenoquine Price by Type (2021-2032)
- 8.2 North America Tafenoquine Market Size by Application
- 8.2.1 North America Tafenoquine Revenue by Application (2021-2032)
- 8.2.2 North America Tafenoquine Sales by Application (2021-2032)
- 8.2.3 North America Tafenoquine Price by Application (2021-2032)
- 8.3 North America Tafenoquine Market Size by Country
- 8.3.1 North America Tafenoquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Tafenoquine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Tafenoquine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Tafenoquine Market Size by Type
- 9.1.1 Europe Tafenoquine Revenue by Type (2021-2032)
- 9.1.2 Europe Tafenoquine Sales by Type (2021-2032)
- 9.1.3 Europe Tafenoquine Price by Type (2021-2032)
- 9.2 Europe Tafenoquine Market Size by Application
- 9.2.1 Europe Tafenoquine Revenue by Application (2021-2032)
- 9.2.2 Europe Tafenoquine Sales by Application (2021-2032)
- 9.2.3 Europe Tafenoquine Price by Application (2021-2032)
- 9.3 Europe Tafenoquine Market Size by Country
- 9.3.1 Europe Tafenoquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Tafenoquine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Tafenoquine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Tafenoquine Market Size by Type
- 10.1.1 China Tafenoquine Revenue by Type (2021-2032)
- 10.1.2 China Tafenoquine Sales by Type (2021-2032)
- 10.1.3 China Tafenoquine Price by Type (2021-2032)
- 10.2 China Tafenoquine Market Size by Application
- 10.2.1 China Tafenoquine Revenue by Application (2021-2032)
- 10.2.2 China Tafenoquine Sales by Application (2021-2032)
- 10.2.3 China Tafenoquine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Tafenoquine Market Size by Type
- 11.1.1 Asia Tafenoquine Revenue by Type (2021-2032)
- 11.1.2 Asia Tafenoquine Sales by Type (2021-2032)
- 11.1.3 Asia Tafenoquine Price by Type (2021-2032)
- 11.2 Asia Tafenoquine Market Size by Application
- 11.2.1 Asia Tafenoquine Revenue by Application (2021-2032)
- 11.2.2 Asia Tafenoquine Sales by Application (2021-2032)
- 11.2.3 Asia Tafenoquine Price by Application (2021-2032)
- 11.3 Asia Tafenoquine Market Size by Country
- 11.3.1 Asia Tafenoquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Tafenoquine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Tafenoquine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Tafenoquine Market Size by Type
- 12.1.1 SAMEA Tafenoquine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Tafenoquine Sales by Type (2021-2032)
- 12.1.3 SAMEA Tafenoquine Price by Type (2021-2032)
- 12.2 SAMEA Tafenoquine Market Size by Application
- 12.2.1 SAMEA Tafenoquine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Tafenoquine Sales by Application (2021-2032)
- 12.2.3 SAMEA Tafenoquine Price by Application (2021-2032)
- 12.3 SAMEA Tafenoquine Market Size by Country
- 12.3.1 SAMEA Tafenoquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Tafenoquine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Tafenoquine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Tafenoquine Value Chain Analysis
- 13.1.1 Tafenoquine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Tafenoquine Production Mode & Process
- 13.2 Tafenoquine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Tafenoquine Distributors
- 13.2.3 Tafenoquine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst